Top Clinical Trials companies in Poland by Net Cash Used Provided By Financing Activities
Poland
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 61.07 M
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
|
| 2 |
USD 13.88 M
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
| 3 |
USD 9.37 M
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
| 4 |
USD 5.27 M
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
| 5 |
USD -175.23 K
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
| 6 |
USD -7.85 M
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
Frequently Asked Questions
-
Which Clinical Trials company in Poland has the highest Net Cash Used Provided By Financing Activities ?
The Clinical Trials company in Poland with the highest Net Cash Used Provided By Financing Activities is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD 61.07 M.
-
Which Clinical Trials company in Poland has the lowest Net Cash Used Provided By Financing Activities ?
The Clinical Trials company in Poland with the lowest Net Cash Used Provided By Financing Activities is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at USD -7.85 M.
-
What are the top 10 Clinical Trials companies in Poland by Net Cash Used Provided By Financing Activities ?
The top 10 Clinical Trials companies in Poland by Net Cash Used Provided By Financing Activities are Ryvu Therapeutics S.A., Molecure S.A., Captor Therapeutics Spolka Akcyjna, Poltreg S.A., Medinice S.A. and Selvita S.A..
-
What are the bottom 10 Clinical Trials companies in Poland by Net Cash Used Provided By Financing Activities ?
The bottom 10 Clinical Trials companies in Poland by Net Cash Used Provided By Financing Activities are Selvita S.A., Medinice S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, Molecure S.A. and Ryvu Therapeutics S.A..
